產(chǎn)品搜索
相關(guān)文章
聯(lián)系我們
電話:4008750250
號碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號
Email: zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > kinase激酶細(xì)胞株 > CBP73279c-Kit N822K/BaF3
- 詳細(xì)內(nèi)容
CBP73279 | |
I. Introduction | |
Cell Line Name: | c-Kit N822K/BaF3 |
Host Cell: | Ba/F3 |
Stability: | 16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Freeze Medium: | 90% FBS+10% DMSO |
Complete Culture Medium: | RPMI-1640+10%FBS+2ug/ml puromycin |
Mycoplasma Status: | Negative |
II.Background | |
KIT N822K lies within the activation loop in the protein kinase domain of the Kit protein (PMID: 24205792). N822K results in constitutive activation of Kit, increased Erk1/2 and Stat3 phosphorylation, is transforming in culture (PMID: 24205792, PMID: 31484543), leads to mislocalization of Kit to endolysosomes (PMID: 31484543), and has been identified as a secondary mutation associated with imatinib-resistance (PMID: 18488160). | |
III. Representative Data | |
1.WB of c-Kit N822K/BaF3 | |
2. Sanger of c-Kit N822K/BaF3 | |
3. Anti-proliferation assay Figure 3. CTG Proliferation Assay of BaF3 c-KIT N822K(C4). | |
|